DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

3.45 -0.14 (-3.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IDRA $3.45 -3.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.55
Previous Close $3.59
Daily Range $3.35 - $3.58
52-Week Range $1.94 - $5.48
Market Cap $406.5M
P/E Ratio -7.64
Dividend (Yield) $0.00 (0.0%)
Volume 1,916,113
Average Daily Volume 2,050,091
Current FY EPS -$0.46

Sector

Healthcare

Industry

Drug Makers

Idera Pharmaceuticals, Inc. (IDRA) Description

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants. Website: http://www.iderapharma.com/

News & Commentary Rss Feed

Why Idera Pharmaceuticals Inc. Shares Roared Higher

Idera Pharmaceuticals shares pop following the release of the company's first-quarter earnings results.

Idera Pharmaceuticals (IDRA): Today's Weak On High Volume Stock

Idera Announces FDA Orphan Drug Designation for IMO-8400 for the Treatment of Diffuse Large B-Cell L

Idera Announces FDA Orphan Drug Designation for IMO-8400 for the Treatment of Diffuse Large B-Cell Lymphoma

Idera Pharmaceuticals (IDRA) Weak On High Volume

Idera Pharmaceuticals (IDRA) In A Perilous Reversal

Cowen & Co Remains Bullish on Celldex Therapeutics Following FDA 'Breakthrough' Approval

Biotech Stocks Moving Higher

One Reason Idera Pharmaceuticals (IDRA) Stock is Up Today

Health Care Sector Update for 02/13/2015:

Morning Market Losers

Morning-Market Movers Led By Aeropostale, Coca-Cola & Coupons.Com

See More IDRA News...

IDRA's Top Competitors

IDRA $3.45 (-3.90%)
Current stock: IDRA
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB